Methadone more effective than buprenorphine/naloxone for treatment retention of opioid use disorder: JAMA Dr. Kamal Kant Kohli22 Oct 2024 3:30 PMPeople with opioid use disorder in British Columbia who received methadone had a 37-40 per cent lower rate of treatment discontinuation compared with...
Naloxone Addition to Opioid Mixture may reduce Pruritis in Spinal Anesthesia for Cesarean Section, finds study Dr Monish Raut21 Oct 2024 2:30 PMRegional anesthesia techniques, such as spinal anesthesia, are frequently employed for cesarean section (CS) due to their benefits of providing...
Naloxone successfully reverses signs of opioid overdose in over half of users in prehospital setting: Study Dr. Kamal Kant Kohli15 Oct 2024 3:00 PMThe opioid epidemic is a leading cause of morbidity and mortality in the United States, and it is increasingly impacting children and teenagers....
First clinical practice guideline for opioid prescriptions released by American Academy of Pediatrics Dr. Kamal Kant Kohli7 Oct 2024 2:30 PMThe American Academy of Pediatrics has published its first clinical guideline for pediatricians on prescribing opioids, including explicit...
Naloxone may improve survival rates among patients with opioid-associated out of hospital cardiac arrest: JAMA Dr. Kamal Kant Kohli28 Aug 2024 1:00 AMPatients who overdose on opioids and have a pulse are often given naloxone (Narcan) by first responders, a common life-saving measure. However,...
Novel potent opioids require higher naloxone dosing than fentanyl, tied to high cardiac arrest rates Jacinthlyn Sylvia9 Sept 2023 5:00 AMSynthetic opioids, particularly the potent fentanyl analogues and the relatively lesser-known nitazene drug class, are rapidly emerging as a...
US District Court rules in favour of Orexo in patent litigation against Sun Pharma on Zubsolv patent Ruchika Sharma5 July 2023 8:00 AMSweden: Orexo AB (publ.), has announced that the US District Court for the District of New Jersey ruled in favor of Orexo in its patent litigation...
Combination therapy of buprenorphine and naloxone safe for treating opioid use disorder during pregnancy Dr. Kamal Kant Kohli14 Jan 2023 4:30 AMCurrent guidelines recommend that pregnant women with opioid use disorder be prescribed either methadone or buprenorphine, but these drugs too have...
Furnish Price to Retailer and Moving Annual Turnover value in respect of 11 Formulations: NPPA Dr. Divya Colin2 Dec 2022 12:30 PMNew Delhi: Taking an appropriate action for fixation of the ceiling prices pursuant to the issue of Revised Schedule-I of DPCO, 2013, the National...
AbbVie, Teva finalize USD 6.6 billion US opioid settlements Ruchika Sharma24 Nov 2022 10:57 AMUS: Teva Pharmaceutical Industries Ltd and AbbVie Inc have finalized the terms of settlements worth more than $6.6 billion to resolve...
Removing the HIGH from the OPIOID: Scientists develop Fentanyl Vaccine that prevents the opiod from entering the brain Dr. Kamal Kant Kohli17 Nov 2022 9:55 AMA research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its...
Coming wave of opioid overdoses Isra Zaman30 July 2022 4:00 AMOver the past 21 years of opioid overdose deaths-from prescription drugs to heroin to synthetic and semisynthetic opioids such as fentanyl-geography...
